DT vs JKHY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Dynatrace exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and a pristine balance sheet (Debt/Equity 0.03). However, there is a severe valuation disconnect, as the current price of $35.29 trades significantly above the Graham Number ($11.13) and Intrinsic Value ($4.20). While the company maintains elite gross margins (81.75%) and a consistent track record of earnings beats, the massive YoY earnings decline (-89.10%) and bearish technical trend (0/100) offset the bullish analyst consensus.
JKHY exhibits exceptional fundamental strength, highlighted by a Piotroski F-Score of 8/9 and a near-zero Debt/Equity ratio of 0.03. While the technical trend is currently bearish (0/100) and the stock is trading well above its defensive Graham Number ($69.24), it remains significantly undervalued relative to its growth-based intrinsic value of $205.91. The company's track record of beating earnings estimates over 25 consecutive quarters provides high confidence in its operational execution. The current price dip represents a compelling entry point for long-term investors despite short-term momentum headwinds.
Compare Another Pair
Related Comparisons
DT vs JKHY: Head-to-Head Comparison
This page compares Dynatrace, Inc. (DT) and Jack Henry & Associates, Inc. (JKHY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.